Muhammad Yasir Qureshi

Muhammad Yasir Qureshi

Auto-generated profile, based on publicly available information

Muhammad Yasir Qureshi

Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JSJay W. Schneider
Jay W. Schneider
SOSaji Oommen
Saji Oommen
MQMuhammad Y. Qureshi
Muhammad Y. Qureshi
SGSean C. Goetsch
Sean C. Goetsch
DPDavid R. Pease
David R. Pease
JFJanell K. Fox
Janell K. Fox

1 July 2015 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
JPJoseph T. Poterucha
Joseph T. Poterucha
JJJonathan N. Johnson
Jonathan N. Johnson
MQM. Yasir Qureshi
M. Yasir Qureshi
POPatrick W. O’leary
Patrick W. O’leary
PKPatrick S. Kamath
Patrick S. Kamath
FCFrank Cetta
Frank Cetta

1 August 2015 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
JTJeanne L. Theis
Jeanne L. Theis
MZMichael Zimmermann
Michael Zimmermann
JEJared M. Evans
Jared M. Evans
BEBruce W. Eckloff
Bruce W. Eckloff
EWEric D. Wieben
Eric D. Wieben
TOTimothy Olson
Timothy Olson
Background—: The molecular underpinnings of hypoplastic left heart are poorly understood. Staged surgical palliation has dramatically improved survival, yet eventual failure of the systemic right ventricle necessitates cardiac transplantation in a subset of patients. We sought to identify genetic determinants of hypoplastic left heart with latent right ventricular dysfunction in individuals with a Fontan circulation. Methods and Results—: Evaluation of cardiac structure and function by echocardiography in patients with hypoplastic left heart and their first-degree relatives identified 5 individuals with right ventricular ejection fraction ≤40% after Fontan operation. Whole genome sequencing was performed on DNA from 21 family members, filtering for genetic variants with allele frequency <1% predicted to alter protein structure or expression. Secondary family-based filtering for de novo and recessive variants revealed rare inherited missense mutations on both paternal and maternal alleles of MYH6 , encoding myosin heavy chain 6, in 2 patients who developed right ventricular dysfunction 3 to 11 years postoperatively. Parents and siblings who were heterozygous carriers had normal echocardiograms. Protein modeling of the 4 highly conserved amino acid substitutions, residing in both head and tail domains, predicted perturbation of protein structure and function. Conclusions—: In contrast to dominant MYH6 mutations with variable penetrance identified in other congenital heart defects and dilated cardiomyopathy, this study reveals compound heterozygosity for recessive MYH6 mutations in patients with hypoplastic left heart and reduced systemic right ventricular ejection fraction. These findings implicate a shared molecular basis for the developmental arrest and latent myopathy of left and right ventricles, respectively.

1 September 2016 in JACC
Verified
Journal Article
Closed access
AEAlexander C. Egbe
Alexander C. Egbe
HCHeidi M. Connolly
Heidi M. Connolly
CMChristopher J. McLeod
Christopher J. McLeod
NANaser M. Ammash
Naser M. Ammash
TNTalha Niaz
Talha Niaz
DDDavid J. Driscoll
David J. Driscoll

1 January 2017 in American Heart Journal
Verified
Journal Article
Closed access
AEAlexander C. Egbe
Alexander C. Egbe
HCHeidi M. Connolly
Heidi M. Connolly
TNTalha Niaz
Talha Niaz
VYVidhushei Yogeswaran
Vidhushei Yogeswaran
NTNathaniel W. Taggart
Nathaniel W. Taggart
DDDavid J. Driscoll
David J. Driscoll

1 March 2015 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HBHarold M Burkhart
Harold M Burkhart
MQMuhammad Yasir Qureshi
Muhammad Yasir Qureshi
SPSusana Cantero Peral
Susana Cantero Peral
POPatrick W O'Leary
Patrick W O'Leary
TOTimothy M Olson
Timothy M Olson
WGWanek Program Clinical Pipeline Group
Wanek Program Clinical Pipeline Group